These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11584333)

  • 41. The role of sarcoplasmic reticulum in the protective effect of class III drugs against Ca2+ overload.
    Manoach M; Varon D; Tribulova N; Zinman T; Kaplan D; Khananshvili D; Shainberg A
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():19-25. PubMed ID: 10707827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmural changes in size, contractile and electrical properties of SHR left ventricular myocytes during compensated hypertrophy.
    McCrossan ZA; Billeter R; White E
    Cardiovasc Res; 2004 Aug; 63(2):283-92. PubMed ID: 15249186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tedisamil (KC 8857) is a new specific bradycardic drug: does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease.
    Thormann J; Mitrovic V; Riedel H; Neuzner J; Strasser R; Bahavar H; Schlepper M
    Am Heart J; 1993 May; 125(5 Pt 1):1233-46. PubMed ID: 8480574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 45. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers.
    Démolis JL; Martel C; Funck-Brentano C; Sachse A; Weimann HJ; Jaillon P
    Br J Clin Pharmacol; 1997 Oct; 44(4):403-9. PubMed ID: 9354317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of E-4031, almokalant and tedisamil on postrest action potential duration of human papillary muscles.
    Ohler A; Ravens U
    J Pharmacol Exp Ther; 1994 Aug; 270(2):460-5. PubMed ID: 7520940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction in external K causes increased action potential shortening in ventricular myocytes from the spontaneously hypertensive rat.
    Evans SJ; Jones JV; Levi AJ
    J Hypertens; 1997 Jun; 15(6):659-66. PubMed ID: 9218186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tedisamil in coronary disease: additional benefits in the therapy of atrial fibrillation?
    Opie LH
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S33-7. PubMed ID: 12746750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of Na+/H+ exchanger contracts the portal vein of spontaneously hypertensive and Wistar Kyoto rats.
    Bamosa AO
    Indian J Physiol Pharmacol; 1997 Jul; 41(3):211-8. PubMed ID: 10232764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Normal left ventricular diastolic compliance after regression of hypertrophy.
    Schraeger JA; Canby CA; Rongish BJ; Kawai M; Tomanek RJ
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):349-57. PubMed ID: 7515976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The protective effect of class III antiarrhythmic agents against calcium overload in cultured myocytes.
    Manoach M; Varon D; Shainberg A; Zinman T; Isaack A; Rutman IH; Kaplan D; Tribulova N
    Life Sci; 1997; 61(16):PL 227-34. PubMed ID: 9353172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of frusemide, ethacrynic acid and chlorothiazide on the portal vein of normotensive and spontaneously hypertensive rats.
    Tayo FM; Fasanmi OA
    Afr J Med Med Sci; 1984; 13(3-4):161-7. PubMed ID: 6099978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tedisamil: a new novel antiarrhythmic.
    Freestone B; Lip GY
    Expert Opin Investig Drugs; 2004 Feb; 13(2):151-60. PubMed ID: 14996649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mixed blockade of K+ and Na+ currents in rat ventricular myocytes by the tedisamil analogue, KC8851.
    McLarnon JG; Xu R
    Eur J Pharmacol; 1997 Nov; 339(2-3):279-88. PubMed ID: 9473146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium sensitization as a positive inotropic mechanism in diseased rat and human heart.
    Nankervis R; Lues I; Brown L
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):612-7. PubMed ID: 7528844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements.
    Dorian P; Newman D
    Cardiovasc Res; 1997 Feb; 33(2):485-94. PubMed ID: 9074714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tedisamil inhibits the delayed rectifier K+ current in single smooth muscle cells of the guinea-pig portal vein.
    Pfründer D; Kreye VA
    Pflugers Arch; 1992 May; 421(1):22-5. PubMed ID: 1630881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of veratridine and BDF 9148 on the action potentials and contractility of the rat right ventricle.
    Doggrell SA; Bishop BE; Brosch S
    Gen Pharmacol; 1995 May; 26(3):593-601. PubMed ID: 7789734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.